Spinal Cord Stimulation Market to hit US$ 4.95 Billion by 2030 | Exclusive Report by Growth Plus Reports
Growth Plus Reports
3 min read
Growth Plus Reports
Pune, Nov. 29, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global spinal cord stimulation market is expected to clock US$ 4.95 billion by 2030 and to grow at a CAGR of 7.9% during the forecast period. Owing to the technological advancements in spinal cord stimulators globally. This exclusive information is published by Growth Plus Reports in its report titled “Spinal Cord Stimulation Market – Global Outlook & Forecast 2022-2030”
The availability of healthcare facilities, advancements in technology, and the increased demand for minimally invasive surgeries are all contributing to the growth of the global spinal cord stimulation market. The activities of the government encourage the growth of the market. Additionally, the industry can grow thanks to increasing research and development efforts and public awareness. People are becoming more educated about medications, their negative effects, and the methods used to treat pain with them. In the case of SCS, the most popular therapy, HF10, has shown to be more effective.
The global spinal cord stimulation market has been analyzed from three perspectives: product,application and region.
Excerpts from ‘By Product Segmentation’
Based on product, the global spinal cord stimulation market is subdivided into:
Rechargeable
Non-Rechargeable
Rechargeable devices are anticipated to experience the quickest rate of growth throughout the course of the projection period due to their affordability, adaptability, and ability to control pain through wireless remote procedures. Such a gadget prevents neuropathic pain by sending light electrical signals to the spinal cord close to painful locations. It has a battery inside that is easily replaceable by surgery.
Excerpts from ‘By Region Segmentation’
Based on region, the global spinal cord stimulation market has been segmented into
North America
Europe
Asia Pacific
Rest of the World
Asia Pacific region is expected to project a high CAGR during the forecast period. This is attributed to the increasing number of patients suffering from neuropathic pain after spinal surgeries and chronic pain in the legs, arms, and feet owing to trauma and injuries. Rising government support in terms of funding for research and development and penetration of key market players in this region is also driving the spinal cord stimulation market.
Excerpts from ‘Competitive Landscape’
The prominent players operating in the global spinal cord stimulation market are:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
